retatrutide news recency 3 today Retatrutide, an experimental weight-loss drug, has not been approved by People Are Already Taking This

This allows the medication to absorb slowly and steadily into the bloodstream, which is essential for maintaining consistent therapeutic levels throughout the week

Most side effects are mild to moderate and can be managed with dose adjustments

The Phase 2 trial did show that gradual titration significantly reduces GI side effects

While healthy lifestyle habits are key to losing weight, theyre not always effective on their own

Data published in the journal Obesity shows that slightly more than 50% of patients stop using semaglutide or tirzepatide for obesity treatment within a year

The dual activation creates a stronger overall impact on your GI tract